Please use this identifier to cite or link to this item:
Título : Low melatonin as a contributor to SARS-CoV-2 disease
Autor : Pandi Perumal, Seithikurippu R. 
Cardinali, Daniel Pedro 
Reiter, R. 
Brown, Gregory M. 
Fecha de publicación : 2020
Cita : Pandi Perumal, S. R. et al. Low melatonin as a contributor to SARS-CoV-2 disease [en línea]. Melatonin Research. 2020, 3 (4). doi: 10.32794/mr11250079. Disponible en:
Resumen : Abstract: That the pineal gland is a source of melatonin is widely known; however, by comparison, few know of the much larger pool of extrapineal melatonin. That pool is widely distributed in all animals, including those that do not have a pineal gland, e.g., insects. Extrapineal melatonin is not released into the blood but is used locally to function as an antioxidant, anti-inflammatory agent, etc. A major site of action of peripherally-produced melatonin is the mitochondria where it neutralizes reactive oxygen species (ROS) that are generated during oxidative phosphorylation. Its role also includes major actions as an immune modulator reducing overreactions to foreign agents while simultaneously boosting immune processes. During a pandemic such as coronavirus disease 2019 (COVID-19), caused by the virus SARS-CoV-2, melatonin is capable of suppressing the damage inflicted by the cytokine storm. The implications of melatonin in susceptibility and treatment of COVID-19 disease are discussed.
Disciplina: MEDICINA
DOI: 10.32794/mr11250079
Derechos: Acceso abierto
Appears in Collections:Artículos

Files in This Item:
File Description SizeFormat
low-melatonin-contributor.pdf308,45 kBAdobe PDFThumbnail
Show full item record

Page view(s)

checked on Jun 6, 2023


checked on Jun 6, 2023

Google ScholarTM



This item is licensed under a Creative Commons License Creative Commons